Reduction in the Risk of Rejection by Mycophenolate Mofetil Dose Adjustment in Liver Transplant Patients With Side Effects Caused by the Calcineurine Inhibitors

NCT00456235 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

92

Enrollment

OTHER

Sponsor class

Conditions

Liver Transplantation

Interventions

DRUG: Mycophénolate Mofétil
DRUG: Ciclosporine A
DRUG: Tacrolimus

Sponsor

University Hospital, Limoges